WHO Gilead Sciences, GSK, ViiV Healthcare WHEN 1 to 3 years In June 2024, results from a trial of a new medicine to prevent HIV were announced—and they were jaw-dropping. Lenacapavir, a treatment injected once every six months, protected over 5,000 g
Scientists and activists hope that the story will be different for lenacapavir. So far, the FDA has approved the drug only for people who already have HIV thats resistant to other treatments. But Gil… [+657 chars]
